Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Becotatug Vedotin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07707167
What this trial is testing

A Prospective, Exploratory Study of Becotatug Vedotin Plus Putlimab for Neoadjuvant Therapy and Adjuvant Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
LA HNSCC
Jiangsu Cancer Institute & Hospital 35
Large-scale testing (Phase 3)Looking for participantsNCT07481799
What this trial is testing

Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With Oligometastases

Who this might be right for
Oligo-metastatic Cancer
Ming-Yuan Chen 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381699
What this trial is testing

MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
West China Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686926
What this trial is testing

Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanced Esophageal Squamous Cell Carcinoma, Phase II

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT07424664
What this trial is testing

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Who this might be right for
Uterine Cervical Neoplasms, Recurrent; Uterine Cervical Neoplasms, Metastatic; Vulvar Neoplasms; Vaginal Neoplasms
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Looking for participantsNCT07632339
What this trial is testing

Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07393477
What this trial is testing

Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma HNSCC
Sir Run Run Shaw Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07665190
What this trial is testing

Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Hypopharyngeal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT07712029
What this trial is testing

Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With EGFR-Positive

Who this might be right for
Advanced Refractory Solid TumorsEGFR Gene Overexpression
Tianjin Medical University Second Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07496190
What this trial is testing

Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 59
Large-scale testing (Phase 3)Not Yet RecruitingNCT07524413
What this trial is testing

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 514
Testing effectiveness (Phase 2)Looking for participantsNCT07497919
What this trial is testing

Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer

Who this might be right for
Penile Cancer
Fudan University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07531979
What this trial is testing

Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2

Who this might be right for
ESCCTislelizumabChemotherapy+3 more
Tianjin Medical University Cancer Institute and Hospital 93
Testing effectiveness (Phase 2)Looking for participantsNCT07781358
What this trial is testing

Becotatug Vedotin Combined With a PD-1 Inhibitor in the Treatment of Locally Advanced Recurrent Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Hongmeng Yu 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07598318
What this trial is testing

Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations

Who this might be right for
Cholangiocarcinoma
Sir Run Run Shaw Hospital 164
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07692334
What this trial is testing

Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal Junction (GEJ) AdenocarcinomaBecotatug Vedotin+1 more
West China Second University Hospital 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07490119
What this trial is testing

Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer

Who this might be right for
RAS Wild Type mCRC
Fudan University 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683507
What this trial is testing

Becotatug Vedotin Plus PD-1 Inhibitor for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Feng Liu 60
Testing effectiveness (Phase 2)Looking for participantsNCT07518979
What this trial is testing

EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer

Who this might be right for
Penile Cancer
Jiyan Liu 60
Testing effectiveness (Phase 2)Looking for participantsNCT07586124
What this trial is testing

Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Lepu Biopharma Co., Ltd. 80
Next Page